Flu Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4102924
- 130 Pages
- November 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Flu Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Flu Vaccine market segmented into
Pediatrics
Anflu
FluMist
Fluarix
FluLaval
Fluvax/Afluria
Fluvirin
Others
Market by Influenza Viruses
Influenza A viruses
Influenza B viruses
Others
Based on the end-use, the global Flu Vaccine market classified into
Pediatrics
Adults
Based on geography, the global Flu Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca
CSL Limited
GSK
Hualun Biologicalsamong
ID Biomedical Corporation
Johnson & Johnson
MedImmune, LLC
Mylan
Novartis
Pfizer
Protein Sciences Corporaton
Sanofi Pasteur
Serum Institute of India
Sinovac Biotech
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FLU VACCINE INDUSTRY
2.1 Summary about Flu Vaccine Industry
2.2 Flu Vaccine Market Trends
2.2.1 Flu Vaccine Production & Consumption Trends
2.2.2 Flu Vaccine Demand Structure Trends
2.3 Flu Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Fluzone/Vaxigrip
4.2.2 Anflu
4.2.3 FluMist
4.2.4 Fluarix
4.2.5 FluLaval
4.2.6 Fluvax/Afluria
4.2.7 Fluvirin
4.2.8 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pediatrics
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Fluzone/Vaxigrip
5.2.2 Anflu
5.2.3 FluMist
5.2.4 Fluarix
5.2.5 FluLaval
5.2.6 Fluvax/Afluria
5.2.7 Fluvirin
5.2.8 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pediatrics
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Fluzone/Vaxigrip
6.2.2 Anflu
6.2.3 FluMist
6.2.4 Fluarix
6.2.5 FluLaval
6.2.6 Fluvax/Afluria
6.2.7 Fluvirin
6.2.8 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pediatrics
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Fluzone/Vaxigrip
7.2.2 Anflu
7.2.3 FluMist
7.2.4 Fluarix
7.2.5 FluLaval
7.2.6 Fluvax/Afluria
7.2.7 Fluvirin
7.2.8 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pediatrics
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Fluzone/Vaxigrip
8.2.2 Anflu
8.2.3 FluMist
8.2.4 Fluarix
8.2.5 FluLaval
8.2.6 Fluvax/Afluria
8.2.7 Fluvirin
8.2.8 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pediatrics
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Fluzone/Vaxigrip
9.2.2 Anflu
9.2.3 FluMist
9.2.4 Fluarix
9.2.5 FluLaval
9.2.6 Fluvax/Afluria
9.2.7 Fluvirin
9.2.8 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pediatrics
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 CSL Limited
10.1.3 GSK
10.1.4 Hualun Biologicalsamong
10.1.5 ID Biomedical Corporation
10.1.6 Johnson & Johnson
10.1.7 MedImmune, LLC
10.1.8 Mylan
10.1.9 Novartis
10.1.10 Pfizer
10.1.11 Protein Sciences Corporaton
10.1.12 Sanofi Pasteur
10.1.13 Serum Institute of India
10.1.14 Sinovac Biotech
10.2 Flu Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 CSL Limited
10.2.3 GSK
10.2.4 Hualun Biologicalsamong
10.2.5 ID Biomedical Corporation
10.2.6 Johnson & Johnson
10.2.7 MedImmune, LLC
10.2.8 Mylan
10.2.9 Novartis
10.2.10 Pfizer
10.2.11 Protein Sciences Corporaton
10.2.12 Sanofi Pasteur
10.2.13 Serum Institute of India
10.2.14 Sinovac Biotech
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Flu Vaccine Product Type Overview
2.Table Flu Vaccine Product Type Market Share List
3.Table Flu Vaccine Product Type of Major Players
4.Table Brief Introduction of AstraZeneca
5.Table Brief Introduction of CSL Limited
6.Table Brief Introduction of GSK
7.Table Brief Introduction of Hualun Biologicalsamong
8.Table Brief Introduction of ID Biomedical Corporation
9.Table Brief Introduction of Johnson & Johnson
10.Table Brief Introduction of MedImmune, LLC
11.Table Brief Introduction of Mylan
12.Table Brief Introduction of Novartis
13.Table Brief Introduction of Pfizer
14.Table Brief Introduction of Protein Sciences Corporaton
15.Table Brief Introduction of Sanofi Pasteur
16.Table Brief Introduction of Serum Institute of India
17.Table Brief Introduction of Sinovac Biotech
18.Table Products & Services of AstraZeneca
19.Table Products & Services of CSL Limited
20.Table Products & Services of GSK
21.Table Products & Services of Hualun Biologicalsamong
22.Table Products & Services of ID Biomedical Corporation
23.Table Products & Services of Johnson & Johnson
24.Table Products & Services of MedImmune, LLC
25.Table Products & Services of Mylan
26.Table Products & Services of Novartis
27.Table Products & Services of Pfizer
28.Table Products & Services of Protein Sciences Corporaton
29.Table Products & Services of Sanofi Pasteur
30.Table Products & Services of Serum Institute of India
31.Table Products & Services of Sinovac Biotech
32.Table Market Distribution of Major Players
33.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
34.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
35.Table Global Flu Vaccine Market Forecast (Million USD) by Region 2021f-2026f
36.Table Global Flu Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
37.Table Global Flu Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
38.Table Global Flu Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
